雅各臣科研制药：截至二零二五年九月三十日止六个月的中期业绩公告

P h a r m a C o r p o r a t i o n Jacobson Pharma Corporation Limited 2633 •766.6810.05.4%•183.4195.86.3%•142.0140.31.2%•4.2585.03.5021.4%70.0 2,521115,832–– 2,521115,832 1 2 34 3 3 21 4 (A) 15 (B) (i) (ii) 10%393,395,000371,125,000 6 (A) 7 16.5%16.5% 8 (A) 142,035,000140,290,000 (B) 9 12 0.01 10 3% 120.5%0.1% 500,000552,000 6,500,0005,500,000 CDCC 5 to Thrive 766.65.4% 1.2%142.0 II ACEII 16410 22568166226 11 14.2%23.9152,300158.6918.4 —NIAS—AI ESG 23 ArsenolAPL ArsenolATO APLArsenolODDINDINDIII APLArsenol Axicabtagene CiloleucelYikaida TCAR-TYikaida ATPYikaidaBDLBCLDLBCLCAR-TZUMA-7 YikaidaATPCAR-T e-Jacob Pharma2U 1,000 MedtronicSimplera GDP3.1%2.7%GDP 2–3% —— 1,7921,730259.9243.4 766.643.45.4% (CDCC) 97%25.63.3% 17.666.7% 29.76.5%40%38%22% 30.715.3% 5.93.8%4.94.9% 12.46.3%183.413.7 7.637.1% 1.71.2%142.07.62.93.612.4 76.667.65.0 15.28.9 14.84.5% 99.1%99.3% 122.717.2% 100%8.3%19.5%122.7 C.2.1 2410 4.2585.03.509 1617 www.hkexnews.hkwww.jacobsonpharma.com C1 C3 0.01